| Sabrina Jeanette Peros, | |
|
45 Catalina Dr, Brick, NJ 08723-7602 | |
| (848) 448-3735 | |
| Not Available |
| Full Name | Sabrina Jeanette Peros |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 45 Catalina Dr, Brick, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346770963 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 41YS00807500 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sabrina Jeanette Peros, 45 Catalina Dr, Brick, NJ 08723-7602 Ph: (848) 448-3735 | Sabrina Jeanette Peros, 45 Catalina Dr, Brick, NJ 08723-7602 Ph: (848) 448-3735 |
News Archive
The shortage of personal protective equipment (PPE) available to healthcare professionals has become increasingly problematic as Covid-19 cases continue to surge.
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received approval by the U.S. Food and Drug Administration (FDA) to market the therascreen EGFR test as a companion diagnostic to guide the use of Boehringer Ingelheim's new targeted therapy, GILOTRIF™ (afatinib), for treatment of metastatic NSCLC in patients whose tumors have certain EGFR gene mutations.
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, today announced the acquisition of Eon Surgical, Ltd., a late stage development company that has advanced a minimally invasive microlaparoscopy surgical platform technology designed to enhance surgeons' ability to perform scarless surgery while producing better patient outcomes.
Pro 2000, a vaginal microbicide gel designed to reduce women's risk of HIV infection, showed "no evidence that it reduces the risk of HIV infection," according to the results of a series of clinical trials in Africa, Britain's Medical Research Council (MRC) said on Monday, Reuters reports.
A newly available DNA-based prenatal blood test that can identify a pregnancy with Down syndrome can also identify two additional chromosome abnormalities: trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome). The test for all three defects can be offered as early as 10 weeks of pregnancy to women who have been identified as being at high risk for these abnormalities.
› Verified 8 days ago
Christine Schuler, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2557 Hooper Ave, Brick, NJ 08723 Phone: 732-701-3711 | |
Ms. Lauren Maureen Kropa, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 793 Troy Ct, Brick, NJ 08724 Phone: 732-903-4117 | |
Jeanne Quinn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2557 Hooper Ave, Brick, NJ 08723 Phone: 732-701-3711 Fax: 732-701-3709 | |
Ms. Aubree Nicole Nachman, MA CCC SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1683 Route 88, Brick, NJ 08724 Phone: 732-840-5266 | |
Mrs. Julie Ann Ferwerda, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 69 Pacific Ocean Dr, Brick, NJ 08723 Phone: 732-262-1698 | |
Emily Kosch, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2557 Hooper Ave, Brick, NJ 08723 Phone: 732-701-3711 Fax: 732-701-3709 | |
Dawn Dougherty, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2557 Hooper Ave, Brick, NJ 08723 Phone: 732-701-3711 Fax: 732-701-3709 |